Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid Fakhouri

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Current Medical Research and Opinion|March 10, 2017
A risk scoring system to predict coronary stent thrombosisNikesh Malik, Amerjeet S Banning, Mark Belger, et al.
RMD Open|September 21, 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT studyLars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha, et al.
American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.
Plos One|October 3, 2012
Interaction between IRF6 and TGFA genes contribute to the risk of nonsyndromic cleft lip/palateAriadne Letra, Walid Fakhouri, Renata F Fonseca, et al.
Seminars in Arthritis and Rheumatism|June 21, 2022
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysisCynthia Yang, Ross D Williams, Joel N Swerdel, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Current Medical Research and Opinion|March 10, 2017
A risk scoring system to predict coronary stent thrombosisNikesh Malik, Amerjeet S Banning, Mark Belger, et al.
RMD Open|September 21, 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT studyLars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha, et al.
American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.
Plos One|October 3, 2012
Interaction between IRF6 and TGFA genes contribute to the risk of nonsyndromic cleft lip/palateAriadne Letra, Walid Fakhouri, Renata F Fonseca, et al.
Seminars in Arthritis and Rheumatism|June 21, 2022
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysisCynthia Yang, Ross D Williams, Joel N Swerdel, et al.
Pageof 3